BPG is committed to discovery and dissemination of knowledge
Article Quality Tracking
Feyissa GD. Letter to the Editor: Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence - real-world insights for nephrology practice. World J Nephrol 2026; 15(3): 119286 [PMID: 42626019 DOI: 10.5527/wjn.119286]
Reviewer's ID:
02888410
Submitted on:
August 27, 2026, 17:48
Peer-Review:
Anonymous
Reviewer's Country:
Spain
Conflicts-of-interest statement

Reviewers should recognize, acknowledge and disclose any potential conflict of interest that may include (but not be limited) to the following, and inform the editorial office immediately upon discovery of any conflict of interest, stopping if the article review process is underway.

Close personal and/or professional relationship with the author(s); submitted similar or competing manuscripts to BPG or other journals; studied together with the author(s) and/or has former student, resident, fellow, mentor or family relative relationship; and have had in last 5 years collaboration or common grants and/or publications or financial interest with the authors?
Criteria for Article Quality Tracking-Peer-Review

The mission of BPG is to comply with publishing ethics/standards established by the industry and to publish high quality articles. In addition, we strive to make a strict peer-review of each article submitted, and tracking the scientific quality of each is the mission of the editorial board members and/or peer-reviewers.

The following evaluation points are for editorial board members and/or peer-reviewers’ reference only in evaluating an article:

1 Ethics: Does the ethical approval form provided by the author meet the requirements?

2 Methods: Is the experimental method effective? Can it be repeated by fellow researchers (according to adequate textual/citation content presented)?

3 Results: Are the results true and authentic? Is the theory or hypothesis of universal significance validated or partially validated?

4 Figures and tables: Does the author provide perfect tables, line charts and/or graphs? Or, does the author provide figures and tables that are confusing, poorly constructed and/or not well-annotated?

5 Biostatistics: Does the author provide perfect biostatistics data? Or, does the author provide tables and line charts that have mistakes in the data?

6 References: Does the author scientifically and reasonably cite the latest references which are important in this field and related to the scientific problems and research hypotheses addressed in the study? Or, does the author self-cite, omit, mis-cite and/or over-cite references?

7 Language: Does the language in article correctly, clearly and concisely express the information? Or, does the article have multiple grammatical and spelling mistakes?

8 Caveats or drawbacks: What are the caveats or drawbacks for the results?

Comments to Authors
Please make a specific and meaningful evaluation on the objectivity, credibility and scientific quality of the article according to above listed criteria. Please identify which issues have been resolved by the author and which not, what problems still exist, and which method the author intends to adopt to solve the problem in the next step, etc. Your high quality conclusion will also be advantageous for the author’s efforts in conducting future research, will contribute to raising the reader’s interest, and will promote discipline development. Please fill in your detailed comments to authors at below:
Although the sample is big and the data have some interest, the format of letter to editor make difficult to correctly assess the presented results. The discussion and conclusions are written in a telegraphic way that made it hard to understand. In fact, I think that it should had not been published.
Author Awards
1 Award aims: To praise the authors who have made outstanding contributions by publishing original and innovative Basic study, Clinical study, Case report and/or Review in any of the 43 open-access publications of BPG. Their publications represent meaningful contributions towards promoting the ability of readers to get the latest research results and towards the development of medical science. To thank such authors for their contributions, we have set up the ‘Baishideng Distinguished Award’ to track the quality of articles and award the corresponding authors.

2 Selection methods: Editorial board members will track the quality of the published articles in each issue, so that they can recognize excellent articles and categorize them for recommendation. Then, the annual Baishideng Distinguished Award winners will be selected according to the recommendation categories and the academic influence of the articles. The indexes for academic influence of the articles involves the number of citations, clicks and downloads the paper received.

3 Number of awards: Among articles published in the 43 journals of BPG, 12 total articles (3 Reviews, 3 Basic studies, 3 Clinical studies and 3 Case reports) will be recognized and their authors awarded.

4 Award amounts: The first prize will be 5000 USD. The second prize will be 3000 USD. The third prize will be 2000 USD. In addition, each winner will be presented an official certificate for their Baishideng Distinguished Award.

5 List of winners: The list of Baishideng Distinguished Award winners will be announced on the official BPG website.
Editorial board members and/or peer-reviewers should categorize articles according to the following recommendation categories, with consideration to results of the Track Article Quality assessment to identify excellent articles:
Reply from the Authors:
Subject: Response to the Track Article Quality Report Dear Editorial Office, Thank you for inviting me to respond to the Track Article Quality Report concerning my published Letter to the Editor, “Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence—real-world insights for nephrology practice,” published in World Journal of Nephrology. I sincerely appreciate the reviewer’s careful assessment and constructive comments. I acknowledge that the concise format of a Letter to the Editor may have resulted in an overly compressed presentation of the study findings, discussion, and conclusions. I also recognize that some statements may have appeared telegraphic and that the interpretation of the results could have been explained more clearly. The purpose of the letter was to briefly highlight the potential clinical relevance of the retrospective cohort study by Kleinman et al., particularly the association between higher patiromer adherence and greater use of renin–angiotensin–aldosterone system inhibitors. However, I agree that brevity should not compromise clarity, methodological transparency, or appropriate interpretation. In response to the reviewer’s concerns, I would be pleased to prepare and submit a Letter to the Editor addressing the following points: 1. Clarifying the study design, cohort characteristics, adherence definition, outcome measures, and principal findings. 2. Distinguishing clearly between observed associations and causal interpretations. 3. Revising the discussion to avoid overstating the clinical implications of claims-based observational data. 4. Expanding the limitations, including potential residual confounding, the use of proportion of days covered as a proxy for medication adherence, and the limited generalizability of United States claims data. 5. Rewriting the discussion and conclusion in a clearer, more complete, and reader-friendly manner. 6. Correcting any wording that could imply that patiromer adherence definitively improves renal or cardiovascular outcomes, since the available evidence primarily supports an association with continued or increased RAAS inhibitor utilization. I value the peer-review process and agree that post-publication scholarly discussion can help improve the accuracy, clarity, and usefulness of published scientific work. I therefore appreciate the opportunity to respond formally and to clarify the scientific context and limitations of the article. Please confirm whether the proposed response should be submitted through the standard online submission system as a new “Letter to the Editor,” with the original article citation clearly identified. I will follow the journal’s prescribed format and submission requirements. Thank you again for your consideration. Kind regards, Gemechu Dereje Feyissa Assistant Professor Department of Public Health Faculty of Health Sciences, Rift Valley University Adama, Oromia, Ethiopia ORCID: 0009-0009-9248-4084 Email: gemechudereje80@gmail.com